XML 24 R71.htm IDEA: XBRL DOCUMENT v2.4.0.8
Revenues from sales by product for the years ended December 31, 2013 and 2012 are as follows (in thousands): (Details) (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Revenues from sales productwise    
HITOX $ 14,004 $ 18,453
ALUPREM 14,662 14,208
BARTEX / BARYPREM 7,882 7,401
HALTEX / OPTILOAD 3,427 3,662
TIOPREM 1,817 1,799
SR 3,527 10,410
OTHER 702 720
Total $ 46,021 $ 56,653
HITOX percentage to sales revenue 30.00% 33.00%
ALUPREM percentage to sales revenue 32.00% 27.00%
BARTEX / BARYPREM percentage to sales revenue 17.00% 11.00%
HALTEX / OPTILOAD percentage to sales revenue 8.00% 7.00%
TIOPREM percentage to sales revenue 4.00% 3.00%
SR percentage to sales revenue 8.00% 18.00%
OTHER percentage to sales revenue 1.00% 1.00%
Total percentage to sales revenue 100.00% 100.00%